Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a… bypharmanewsdailyAugust 15, 2018
